BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 31023613)

  • 1. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25 720 Patients With Stage IA to IV Melanoma.
    Helvind NM; Brinch-Møller Weitemeyer M; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
    JAMA Dermatol; 2023 Nov; 159(11):1213-1222. PubMed ID: 37650576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of AJCC staging system and proposal of a novel stage grouping system in retroperitoneal liposarcoma: the Fudan Zhongshan experience.
    Fan P; Tao P; Wang Z; Wang J; Hou Y; Lu W; Ma L; Zhang Y; Tong H
    Front Oncol; 2024; 14():1373762. PubMed ID: 38601763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
    Janczewski LM; Browner A; Cotler J; Nelson H; Ballman KV; LeBlanc M; Gollub MJ; Eng C; Brierley JD; Palefsky JM; Goldberg RM; Goodman KA; Washington MK; Asare EA; Palis B
    Cancer; 2024 May; 130(9):1702-1710. PubMed ID: 38140735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new lymph node ratio-based staging system for rectosigmoid cancer: a retrospective study with external validation.
    Zhang C; Zhao S; Wang X; Wen D
    Int J Surg; 2023 Oct; 109(10):3087-3096. PubMed ID: 37462992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses.
    Stålhammar G; Coupland SE; Ewens KG; Ganguly A; Heimann H; Shields CL; Damato B
    Ophthalmology; 2024 Apr; 131(4):478-491. PubMed ID: 38071620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database.
    Gao P; Song YX; Wang ZN; Xu YY; Tong LL; Sun JX; Yu M; Xu HM
    BMC Cancer; 2013 Mar; 13():123. PubMed ID: 23496812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
    Varey AHR; Li I; El Sharouni MA; Simon J; Dedeilia A; Ch'ng S; Saw RPM; Spillane AJ; Shannon KF; Pennington TE; Rtshiladze M; Stretch JR; Nieweg OE; van Akkooi A; Sullivan RJ; Boland GM; Gershenwald JE; van Diest PJ; Scolyer RA; Long GV; Thompson JF; Lo SN
    J Clin Oncol; 2024 Apr; 42(10):1169-1180. PubMed ID: 38315961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?
    Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC
    Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era.
    Hagopian G; Jiang X; Grant C; Brazel D; Kumar P; Yamamoto M; Jakowatz J; Chow W; Tran T; Shen W; Moyers J
    ESMO Open; 2024 Feb; 9(2):102193. PubMed ID: 38271786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer.
    Janczewski LM; Faski J; Nelson H; Gollub MJ; Eng C; Brierley JD; Palefsky JM; Goldberg RM; Washington MK; Asare EA; Goodman KA;
    CA Cancer J Clin; 2023; 73(5):516-523. PubMed ID: 37114458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised TN categorization for colon cancer based on national survival outcomes data.
    Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart AK
    J Clin Oncol; 2010 Jan; 28(2):264-71. PubMed ID: 19949014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic validation and therapeutic decision-making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy.
    Wu SG; Wang J; Lei J; Lian CL; Hua L; Zhou J; He ZY
    Clin Transl Med; 2020 Jan; 10(1):125-136. PubMed ID: 32508053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
    Haydu LE; Lo SN; McQuade JL; Amaria RN; Wargo J; Ross MI; Cormier JN; Lucci A; Lee JE; Ferguson SD; Saw RPM; Spillane AJ; Shannon KF; Stretch JR; Hwu P; Patel SP; Diab A; Wong MKK; Glitza Oliva IC; Tawbi H; Carlino MS; Menzies AM; Long GV; Lazar AJ; Tetzlaff MT; Scolyer RA; Gershenwald JE; Thompson JF; Davies MA
    J Clin Oncol; 2020 May; 38(13):1429-1441. PubMed ID: 31990608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study.
    Liu Q; Lian P; Luo D; Cai S; Li Q; Li X
    Onco Targets Ther; 2018; 11():5827-5834. PubMed ID: 30271165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing T2-T3 staging of penile cancer according to the American Joint Committee on cancer 8
    Kakoti S; Sureka SK; Pathak A; Shah US; Mishra N; Puneeth Kumar KM; Srivastava A; Singh UP
    Indian J Urol; 2023; 39(1):53-57. PubMed ID: 36824107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French updated recommendations in Stage I to III melanoma treatment and management.
    Guillot B; Dalac S; Denis MG; Dupuy A; Emile JF; De La Fouchardiere A; Hindie E; Jouary T; Lassau N; Mirabel X; Piperno Neumann S; De Raucourt S; Vanwijck R
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):594-602. PubMed ID: 28120528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
    Vikström S; Syriopoulou E; Andersson TM; Eriksson H
    J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts.
    Fastner S; Shen N; Hartman RI; Chu EY; Kim CC; Kirkwood JM; Grossman D
    Cancer Med; 2023 Dec; 12(24):22103-22108. PubMed ID: 38098216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.